Navigation Links
Par Pharmaceutical Companies Reports Third Quarter 2011 Results
Date:11/2/2011

TSCurrent assets:Cash and cash equivalents$225,969$218,674Available for sale marketable debt securities30,86127,866Accounts receivable, net  98,10395,705Inventories80,98672,580Prepaid expenses and other current assets22,53717,660Deferred income tax assets31,00526,037Income taxes receivable37,86418,605Total current assets527,325477,127Property, plant and equipment, net69,66571,980Intangible assets, net63,42495,467Goodwill63,72963,729Other assets6,4955,441Non-current deferred income tax assets, net55,45169,488Total assets$786,089$783,232LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$21,551$23,956Payables due to distribution agreement partners53,47325,310Accrued salaries and employee benefits 11,66016,397Accrued government pricing liabilities39,82432,169Accrued legal fees7,2967,084Accrued legal settlements37,800-Accrued expenses and other current liabilities6,0566,674Total current liabilities177,660111,590Long-term liabilities44,79143,198Commitments and contingencies--Stockholders' equity:Common Stock, par value $0.01 per share, authorized 90,000,000 shares; issued39,662,618 and 38,872,663 shares394389Additional paid-in capital394,468373,764Retained earnings251,140329,129Accumulated other comprehensive (loss) income(21)137Treasury stock, at cost 3,180,643 and 2,970,573 shares(82,343)(74,975)Total stockholders' equity563,638628,444Total liabilities and stockholders' equity$786,089$783,232PAR PHARMACEUTICAL COMPANIES, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In Thousands, Except Per Share Data)

(Unaudited)Three months endedNine months endedSeptember 30,September 30,September 30,September 30,2011201020112010Revenues:Net product sales

$208,865$226,131$644,672$763,148Other product related revenues

6,4928,30927,82518,698Total revenues

215,357234,440672,497781,846Cost of goods sold

130,253131,146378,714503,583Gross margin

85,104103,294293,783278,263Operating expenses:Research and development'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... New York , July 25, 2014 ... by Transparency Market Research "Global and China Insulin Market ... - Industry Analysis, Size, Share, Growth, Trends and Forecast ... market was valued at USD 19.99 billion in 2012 ... 6.1% from 2013 to 2019 to reach USD 32.24 ...
(Date:7/25/2014)... July 25, 2014  Semler Scientific, Inc. (Nasdaq: ... risk assessment company that develops patented products that ... chronic diseases, today reported financial results for the ... 2014. "The second quarter of ... Doug Murphy-Chutorian , M.D., chief executive officer ...
(Date:7/24/2014)...   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... for Zalviso remains July 27, 2014.  The ... the Food and Drug Administration (FDA) had approved Zalviso.  ... notification to the company from the FDA regarding the ...
Breaking Medicine Technology:Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2
(Date:7/27/2014)... Zensah®, the leader in compression technology and sports medicine, has ... . The wrist support features an adjustable velcro strap and ... Epicondylitis, more commonly referred to as tennis elbow and golfers ... the tendons attached to the outside of the elbow. Although ... work the wrist and fingers turn into a tendon that ...
(Date:7/27/2014)... 28, 2014 Recently, Wdsshop.de, a reliable online ... collection of fabulous prom dresses on its website. ... prices, up to 58% off. , “We are pleased to ... line. They are specially created for those who are in ... great and vivid in style. I think our clients will ...
(Date:7/27/2014)... (PRWEB) July 27, 2014 Bags underneath the ... suffer from globally and there are a range of new ... is now promoting a baggy eyes serum review that is ... , The review explores the issues with baggy eyes and ... appearance for serum users. The guide also provides a detailed ...
(Date:7/27/2014)... The first systematic analysis of hepatitis E virus (HEV) ... 3000 donors in England have HEV in their plasma. ... that around 1200 HEV-containing blood components (eg, red cells, ... transfused every year in England. , The study ... south east England between Oct, 2012 and Sept, 2013 ...
(Date:7/27/2014)... July 27, 2014 Ticket Down is ... The Forum in Inglewood, California on November 15th. This ... fans can expect to hear songs from this amazing album at ... concert in Inglewood, California at The Forum will be released for ... 10:00 a.m. today local time TicketDown.com. This popular secondary ticket ...
Breaking Medicine News(10 mins):Health News:Zensah® Releases New Wrist Support 2Health News:Wdsshop.de Unveils New Prom Dresses To Expand The Online Market 2Health News:Baggy Eyes Serum Review Posted for Men and Women at Cherry News Website 2Health News:The Lancet: 1 in 3000 blood donors in England infected with hepatitis E 2Health News:5 Seconds of Summer Tickets at The Forum in Inglewood (Los Angeles), CA Now Available For Sale at Ticket Down 2
... ... and networking resources , ... CO (Vocus) August 5, 2009 -- MedHunters is making it easier for qualified ... redesigned to include:, , ,   Niche Web ...
... ... ... -- In 1999 Christina Timmons parlayed a background in health care marketing and public relations ... , a physician job search website that will celebrate its 10th anniversary in ...
... , , Unprecedented Collaboration ... SILVER SPRING, Md., Aug. 5 For the first ... Medicine Physician Certification (OMPC) Examination. The 18-month process of establishing an ... expected completion in March 2010. According to Dr. Robert Kushner, Chair ...
... ... never develop symptoms, a phenomenon that has puzzled scientists since the first genetic mutation was ... have figured out why these mutation carriers are protected from symptoms of the disorder - ... ...
... , ALISO VIEJO, Calif., Aug. 4 ... premier anatomic pathology and molecular testing services resource for pathologists, oncologists and ... six months ended June 30, 2009. Financial results included a 40 ... second quarter of 2008, and a 43 percent increase in revenue for ...
... , Who: Jordan Thomas, 2009 National Courage Award recipient, ... traumatic injury, Events: Adapted ... Monday, Aug. 10, 2009, 8:30 a.m. to noon, ... Medtronic Celebration of Courage Gala, ...
Cached Medicine News:Health News:MedHunters Launches Redesigned Web Platform 2Health News:Ten Years Later: O.I.S. Media Leads Physician Job Board Industry with Innovative Technology 2Health News:Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 2Health News:Abnormal Brain Circuits May Prevent Movement Disorder 2Health News:Abnormal Brain Circuits May Prevent Movement Disorder 3Health News:Abnormal Brain Circuits May Prevent Movement Disorder 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 2Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 3Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 4Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 5Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 6Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 7Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 8Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 9Health News:Clarient Reports Second Quarter Revenue Up 40 Percent 10Health News:National Courage Award Winner Jordan Thomas to Participate in PGA Adapted Youth Golf Clinic 2
Includes conservation device, standard cannula, batteries and instruction booklet....
Oxygen Conservation Device. Bypass 6203: Turn knob....
... The Forceps are designed to ... locking mechanism which is useful for ... When the blades are closed, the ... Pincher and Adjuster are designed to ...
... Rhein Medical announces its new CVD ... allow the incredible sharpness of diamonds to ... Proven diamond blade sharpness improves stromal reapproximation, ... result. The knives offer unlimited uses, and ...
Medicine Products: